KIMES 2012

Notching up the superlatives

Korea’s largest healthcare festival and the biggest in the fair’s history confirmed the event’s importance this February when the 28th Korean International Medical & Hospital Equipment Show (KIMES) proved to be an amazing show of medical technology.

Photo: KIMES 2012
Photo: KIMES 2012

This year’s event had to be scheduled a month earlier than usual, due to the Nuclear Security Summit drawing representatives from 50 leading countries to Seoul in March. Nonetheless, 1,436 international and domestic medical manufacturers were at KIMES 2012, taking the exhibitor record higher than ever. Breakdown: 458 Korean firms and 978 foreign, including the USA: 121, Japan: 75, China and Germany: 77, Taiwan: 36, Italy: 18 and England: 14 companies.

About 30,000 advanced medical devices, hospital equipment and healthcare products were exhibited for around 60,000 visitors, including 2,000 foreign buyers from 70 countries. Hosting the show, the Korea Medical Devices Industrial Cooperative Association and Korea Medical Devices Industry Association expected to make KRW 1.4 trillion from domestic consultations and $470 million from export consultations.

During KIMES more than 60 medical equipment seminars were conducted, as well as a conference on hospital/clinic management and financial technology for medical personnel.

If you need more information about KIMES please see webpage or contact Sean Shin by Email: .



More on the subject:
Read all latest stories

Related articles


Patient management solutions

Philips acquires start-up Medumo

Royal Philips announced that it has expanded its patient management solutions in the US with the acquisition of Boston-based start-up company Medumo. Founded in 2013, Medumo has developed a…


Aiming to drive health investments

Dubai’s notable healthcare

Formed in 2007 – under the directives of Sheikh Mohammed bin Rashid Al Maktoum, the Vice President, Prime Minister, and Ruler of Dubai, UAE – the Dubai Health Authority (DHA) oversees the…



Partnership to enhance pharma drug development and single cell research

Olympus and Cytosurge AG, developer of the disruptive and patented FluidFM technology, announced their collaboration to significantly expand the awareness and availability of the FluidFM BOT* – a…